The α1-6-fucosyltransferase gene and its biological significance

Biochimica et Biophysica Acta - General Subjects

Volumn 1473, Issue 1, 1999, Pages 9-20

  Miyoshi, Eiji ^a   Noda, Katsuhisa ^a   Yamaguchi, Yukihiro ^a   Inoue, Shinya ^a   Ikeda, Yoshitaka ^a   Wang, Wenge ^a   Ko, Jeong Heon ^a   Uozumi, Naofumi ^a   Li, Wei ^a   Taniguchi, Naoyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Hepatoma; Platelet; Fetoprotein; 1 6 Fucosyltransferase

Indexed keywords

ALPHA 1,6 FUCOSYLTRANSFERASE; ALPHA FETOPROTEIN; FUCOSYLTRANSFERASE; UNCLASSIFIED DRUG; COMPLEMENTARY DNA; GLYCOPROTEIN 6 ALPHA L FUCOSYLTRANSFERASE; GLYCOPROTEIN 6-ALPHA-L-FUCOSYLTRANSFERASE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHROMOSOME MAP; ENZYME ANALYSIS; FUCOSYLATION; GENE EXPRESSION; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TISSUE DISTRIBUTION; ANIMAL; BLOOD; CELL CULTURE; CELL LINE; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; LIVER TUMOR; LONG EVANS RAT; METABOLISM; MOUSE; NUDE MOUSE; RAT; REVIEW; SWINE; THROMBOCYTE;

ANIMALIA; MUS MUSCULUS; SUIDAE;

ALPHA-FETOPROTEINS; ANIMALS; BLOOD PLATELETS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; FUCOSYLTRANSFERASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MICE; MICE, NUDE; RATS; RATS, LONG-EVANS; SWINE; TUMOR CELLS, CULTURED;

EID: 0033530559     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(99)00166-X     Document Type: Review

References (94)

1. Hakomori S.-I. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv. Cancer Res. 52:1989;257-331.
2. Wilson J.R., Willams D., Schachter H. The control of glycoprotein synthesis: N-acetylglucosamine linkage to α mannose residue as a signal of L-fucose to the asparagine-linked N-acetylglucosamine residue of glycopeptide from α1-acid glycoprotein. Biocehem. Biophys. Res. Commun. 72:1976;909-916.
3. Longmore G.D., Schachter H. Product-identification and substrate specificity studies of the GDP-fucose:2-acetamide-2-deoxy-β-D-glucoside (Fuc-linked GlcNAc)6-α-L-fucosyltransferase in a Golgi-rich fraction from porcine liver. Carbohydr. Res. 100:1982;365-392.
4. Shimizu H., Ochiai K., Ikenaka K., Mikoshiba K., Hase S. Structures of N-linked sugar chains expressed mainly in mouse brain. J. Biochem. 114:1993;334-338.
5. Yamashita K., Liang C.-J., Funakoshi S., Kobata A. Structural studies of asparagine-linked sugar chains of human ceruloplasmin. J. Biol. Chem. 256:1981;1283-1289.
6. Yamashita K., Ideo H., Ohkura T., Fukushima K., Yuasa I., Ohno K., Takeshita K. Sugar chains of serum transferrin from patients with carbohydrate deficient glycoprotein syndrome. J. Biol. Chem. 268:1993;5783-5789.
7. Santer U.V., Glick M.C. Partial structure of a membrane glycopeptide from virus-transformed hamster cells. Biochemistry. 18:1979;2533-2540.
8. Brzborowicz J., Mackiewicz A., Brzborowicz D. Microheterogeneity of α-fetoprotein in patient serum as demonstrated by lectin affino-electrophoresis. Scand. J. Immunol. 14:1981;15-20.
9. Taketa K., Ichikawa E., Umetsu K., Suzuki T. Allomyrina dichotoma lectin-nonreactive α-fetoprotein in hepatocellular carcinoma and other tumors: comparison with Ricinus communis agglutinin-I. Cancer Lett. 31:1986;325-331.
10. Champion B., Léger D., Wieruszeski J-M., Montreuil J., Spik G. Presence of fucosylated triantennary, tetraantennary and pentaantenary glycans in transferrin synthesized by the human hepatocarcinoma cell line HepG2. Eur. J. Biochem. 184:1989;405-413.
11. Kóscielak J., Pacuszka T., Kubin J., Zdziechowska H. Serum α-6-L-fucosyltransferase is released from platelets during clotting of blood. Glycoconjug. J. 4:1987;43-49.
12. Kóscielak J., Antoniewicz-Papis J., Zdebska E., Maj S., Leszko B. Activity of platelet α-6-fucosyltransferase is inversely related to blood platelet concentration. Acta Biochim. Pol. 42:1995;35-39.
13. Tatsumura T., Sato H., Mori A., Komori Y., Yamamoto K., Fukutani G., Kuno S. Clinical significance of fucose level in glycoprotein fraction of serum in patients with malignant tumors. Cancer Res. 37:1977;4101-4103.
14. Voynow J.A., Kaiser R.S., Scanlin T.F., Glick M.C. Purification and characterization of GDP-L-Fuc:N-acetyl-β-D-glucosaminide α1-6 fucosyltransferase from culture human skin fibroblasts. J. Biol. Chem. 266:1991;21572-21577.
15. Uozumi N., Yanagidani S., Miyoshi E., Ihara Y., Sakuma T., Gao C.X., Teshima T., Fujii S., Shiba T., Taniguchi N. Purification and cDNA cloning of porcine brain GDP-L-Fuc:N-acetyl-β-D-glucosaminide:α1-6 fucosyltransferase. J. Biol. Chem. 271:1996;27810-27817.
16. Yanagidani S., Uozumi N., Ihara Y., Miyoshi E., Yamaguchi N., Taniguchi N. Purification and cDNA cloning of GDP-L-Fuc:N-acetylglucosaminide:α1-6 fucosyltransferase (α1-6FucT) from human gastric cancer MKN45 cells. J. Biochem. 121:1997;626-632.
17. Kaminska J., Glick M.C., Koscielak J. Purification and characterization of GDP-L-Fuc:N-acetyl β-D-glucosaminide α→6 fucosyltransferase from human blood platelets. Glycoconjug. J. 15:1998;783-788.
18. Wesley A., Forstner J., Qureshi R., Mantle M., Forstner G. Human intestinal mucin in cystic fibrosis. Pediatr. Res. 17:1983;65-69.
19. Lamblin G., Boersma A., Klein A., Roussel P., van Halbeek H., Vliegenthart J.F. Primary structure determination of five sialylated oligosaccharides derived from bronchial mucus glycoproteins of patients suffering from cystic fibrosis. The occurrence of the NeuAc α(2-3)Gal β(1-4)[Fuc α(1-3)] GlcNAc β(1-) structural element revealed by 500-MHz 1H NMR spectroscopy. J. Biol. Chem. 259:1984;9051-9058.
20. Scanlin T.F., Wang Y.M., Glick M.C. Altered fucosylation of membrane glycoproteins from cystic fibrosis fibroblasts. Pediatr. Res. 19:1985;368-374.
21. Wang Y.M., Hare T.R., Won B., Stowell C.P., Scanlin T.F., Glick M.C., Hard K., van Kuik J.A., Vliegenthart J.F. Additional fucosyl residues on membrane glycoproteins but not a secreted glycoprotein from cystic fibrosis fibroblasts. Clin. Chim. Acta. 188:1990;193-210.
22. Breton C., Oriol R., Imberty A. Conserved structural features in eukaryotic and prokaryotic fucosyltransferases. Glycobiology. 8:1998;87-94.
23. Miyoshi E., Uozumi N., Noda K., Hayashi N., Hori M., Taniguchi N. Expression of α1-6 fucosyltransferase in rat tissues and human cancer cell lines. Int. J. Cancer. 72:1997;1117-1121.
24. Gu J., Nishikawa A., Tsuruoka N., Ohno M., Yamaguchi N., Kangawa K., Taniguchi N. Purification and characterization of UDP-N-acetylglucosamine: α-6-D-mannoside β1-6N-acetylglucosaminyltransferase from a human lung cancer cell line. J. Biochem. 113:1993;614-619.
25. Yamaguchi Y., Fujii J., Inoue S., Uozumi N., Yanagidani S., Ikeda Y., Egashira M., Miyoshi O., Niikawa N., Taniguchi N. Mapping of the α1, 6-fucosyltransferase gene, FUT8, to human chromosome 14q24.3. Cytogenet. Cell Genet. 84:1999;58-60.
26. Reguigne-Arnould I., Coullin P., Mollicone R., Faure S., Fletcher A., Kelly R.J., Lowe J.B., Oriol R. Relative positions of two clusters of human α-L-fucosyltransferases in 19q (FUT1-FUT2) and 19p (FUT6-FUT3-FUT5) within the microsatellite genetic map of chromosome 19. Cytogenet. Cell Genet. 71:1995;158-162.
27. Kukowska-Latallo J.F., Larsen R.D., Nair R.P., Lowe J.B. A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group α (1, 3/1, 4) fucosyltransferase. Genes Dev. 4:1990;1288-1303.
28. McCury R.S., Recinos A. III, Olsen A.S., Gingrich J.C., Szczepaniak D., Cameron H.S., Krauss R., Weston B.W. Physical maps of human α (1, 3)fucosyltransferase genes FUT3-FUT6 on chromosomes 19p13.3 and 11q21. Genomics. 26:1995;142-146.
29. Weston B.W., Nair R.P., Larsen R.D., Lowe J.B. Isolation of a novel human α (1, 3) fucosyltransferase gene and molecular comparison to the human Lewis blood group α (1, 3/1, 4) fucosyltransferase gene. Synthetic, homologous, non allelic genes encoding enzymes with distinct acceptor substrate specificities. J. Biol. Chem. 267:1992;4152-4160.
30. Weston B.W., Smith P.L., Kelly R.J., Lowe J.B. Molecular cloning of a fourth member of a human α (1, 3) fucosyltransferase gene family. Multiple homologous sequences that determine expression of the Lewis x, sialyl Lewis x, and difucosyl sialyl Lewis x epitopes. J. Biol. Chem. 267:1992;24575-24584.
31. Goelz S.E., Hession C., Goff D., Griffiths B., Tizard R., Newman B., Chi-Rosso G., Lobb R. ELFT: a gene that directs the expression of an ELAM-1 ligand. Cell. 63:1990;1349-1356.
32. Kumar R., Potvin B., Muller W.A., Stanley P. Cloning of a human α(1, 3)-fucosyltransferase gene that encodes ELFT but does not confer ELAM-1 recognition on Chinese hamster ovary cell transfectants. J. Biol. Chem. 266:1991;21777-21783.
33. x antigens in human-mouse cell hybrids. J. Biol. Chem. 262:1987;15984-15989.
34. Couillin P., Mollicone R., Grisard M.C., Gibaud A., Ravise N., Feingold J., Oriol R. Chromosome 11q localization of one of the three expected genes for the human α-3-fucosyltransferases, by somatic hybridization. Cytogenet. Cell Genet. 56:1991;108-111.
35. Sasaki K., Kurata K., Funayama K., Nagata M., Watanabe E., Ohta S., Hanai N., Nishi T. Expression cloning of a novel α 1, 3-fucosyltransferase that is involved in biosynthesis of the sialyl Lewis x carbohydrate determinants in leukocytes. J. Biol. Chem. 269:1994;14730-14737.
36. Natsuka S., Gersten K.M., Kannagi R., Lowe J.B. Molecular cloning of a cDNA encoding a novel human leukocyte α 1, 3 fucosyltransferase capable of synthesizing the sialyl Lewis x determinant. J. Biol. Chem. 269:1994;16789-16794.
37. Rouquier S., Giorgi D., Bergmann A., Brandriff B., Lennon G. The fucosyltransferase locus FUT1 maps distal to apolipoprotein loci E and C2 on human chromosome 19. Cytogenet. Cell Genet. 66:1994;70-71.
38. Larsen R.D., Ernst L.K., Nair R.P., Lowe J.B. Molecular cloning, sequence, and expression of a human GDP-L-fucose: β-D-galactoside 2-α-L-fucosyltransferase cDNA that can form the H blood group antigen. Proc. Natl. Acad. Sci. USA. 87:1990;6674-6678.
39. Kelly R.J., Rouquier S., Giorgi D., Lennon G.G., Lowe J.B. Sequence and expression of a candidate for the human secretor blood group (1, 2)fucosyltransferase gene (FUT2). J. Biol. Chem. 270:1995;4640-4649.
40. Rouquier S., Lowe J.B., Kelly R.J., Fertitta A.L., Lennon G.G., Giorgi D. Molecular cloning of a human genomic region containing the H blood group (1, 2)fucosyltransferase gene and two H locus-related DNA restriction fragments. J. Biol. Chem. 270:1995;4632-4639.
41. Kaneko M., Kudo T., Iwasaki H., Ikehara Y., Nishihara S., Nakagawa S., Sasaki K., Shiina T., Inoko H., Saitou N., Narimatsu H. α1,3-fucosyltransferase IX (Fuc-TIX) is very highly conserved between human and mouse; molecular cloning, characterization and tissue distribution of human Fuc-TIX. FEBS-Lett. 452:1999;237-242.
42. Costache M., Apoil P.-A., Cailleau A., Elmgren A., Larson G., Henry S., Blancher A., Iordachescu D., Oriol R., Mollicone R. Evolution of fucosyltransferases genes in vertebrates. J. Biol. Chem. 272:1997;29721-29728.
43. Maly P., Thall A.D., Petryniak B., Rogers C.E., Smith P.L., Marks R.M., Kelly R.J., Gersten K.M., Cheng G., Sauders T.L., Camper S.A., Camphausen R.T., Sullivan F.X., Isogai Y., Hindsgaul O., von Andrian U.H., Lowe J.B. The α(1, 3) fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell. 86:1996;643-653.
44. Harry Schachter et al., personal communications.
45. Saito H., Gu J., Nishigawa A., Ihara Y., Fujii J., Kohgo Y., Taniguchi N. Organization of the human N-acetylglucosaminyltransferase V gene. Eur. J. Biochem. 233:1995;18-26.
46. Kang R., Saito H., Ihara Y., Miyoshi E., Koyama N., Sheng Y., Taniguchi N. Transcriptional regulation of the N-acetylglucosaminyl-transferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1. J. Biol. Chem. 271:1996;26706-26712.
47. Buckhaults P., Chen L., Fregien N., Pierce M. Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene. J. Biol. Chem. 272:1997;19575-19581.
48. Tsuji T., Osawa T. Structures of the carbohydrate chains of membrane glycoproteins IIb and IIIa of human platelets. J. Biochem. 100:1986;1387-1398.
49. Koscielak J., Antoniewicz-Papis J., Zdebska E., Maj S., Leszko B. Activity of platelet α-6-fucosyltransferase is inversely related to blood platelet concentration. Acta Biochim. Pol. 42:1995;35-40.
50. Quinto C., Wijfjes A.M., Bloemberg G.V., Blok-Tip L., Lopez-Lara I.M., Lugtenberg B.J.J., Thomas-Oates J.E., Spaink H.P. Bacterial nodulation protein NodZ is a chitin oligosaccharide fucosyltransferase which can also recognize related substrates of animal origin. Proc. Natl. Acad. Sci, USA. 94:1997;4336-4341.
51. Bergstrand C.G., Czar B. Demonstration of new protein fraction in serum from the human fetus. Scand. J. Clin. Lab. Invest. 8:1956;174.
52. Halbrecht I., Klibanski C. Identification of a new normal embryonic hemoglobin. Nature. 178:1956;794-795.
53. Abelev G.I., Perova S.D., Khramkova N.I., Postnikova Z.A., Irlin I.S. Production of embryonal α-globulin by transplantable mouse hepatomas. Transpl. Bull. 1:1963;174-180.
54. Y.S. Tatarinov, The discovery of fetal globulin in patients with primary cancer of the liver, First International Biochemistry Congress of the USSR. Moscow Academy of Sciences USSR, 1963, p. 274.
55. Tatarinov Y.S. Presence of embryo specific α-globulin in the serum of patients with primary hepatocellular carcinoma. Vopr. Med. Khim. 10:1964;90-91.
56. Watabe H. Early appearance of embryonic-globulin in rat serum during carcinogenesis with 4-dimethylaminoazobenzene. Cancer Res. 31:1971;1192-1194.
57. Alpert M.E., Uriel J., de Nechaud B. α1 fetogloblin in the diagnosis of human hepatoma. N. Engl. J. Med. 278:1968;984-986.
58. Ruoslahti E., Salaspuro M., Pihko H., Andersson L., Seppala M. Serum α-fetoprotein: diagnostic significance in liver disease. Br. Med. J. 8:1974;527-529.
59. Di Bisceglie A.M., Hoofnagle J.H. Elevations in serum α-fetoprotein levels in patients with chronic hepatitis B. Cancer. 64:1989;2117-2120.
60. Sawadaishi K., Morinaga T., Tamaoki T. Interaction of a hepatoma-specific nuclear factor with transcription-regulatory sequences of human α-fetoprotein and albumin genes. Mol. Cell Biol. 8:1988;5179-5187.
61. Nakabayashi H., Watanabe K., Saito A., Otsuru A., Sawadaishi K., Tamaoki T. Transcriptional regulation of α-fetoprotein expression by dexamethasone in human hepatoma cells. J. Biol. Chem. 264:1989;266-271.
62. Morinaga T., Sakai M., Wegmann T.G., Tamaoki T. Primary structures of human α-fetoprotein and its mRNA. Proc. Natl. Acad. Sci. USA. 80:1983;4604-4608.
63. Gibbs P.E.M., Zielinski R., Boyd C., Dugaiczyk A. Structure, polymorphism and novel repeated DNA elements revealed by a complete structure of the human α-fetoprotein gene. Biochemistry. 26:1987;1332-1343.
64. Nishi S. Isolation and characterization of a human fetal-alpha-globulin from the sera of fetuses and a hepatoma patient. Cancer Res. 30:1970;2507-2513.
65. H.F. Deutsch, Chemistry and biology of α-fetoprotein, Adv. Cancer Res. 56, pp. 253-312.
66. Breborowicz J., Mackiewicz A., Breborowicz D. Microheterogeneity of α-fetoprotein in patient serum as demonstrated by lectin affino-electrophoresis. Scand. J. Immunol. 14:1981;15-20.
67. Miyazaki J., Endo Y., Oda T. Lectin affinities of α-fetoprotein in liver cirrhosis, hepatocellular carcinoma and metastatic liver tumor. Acta Hepatol. Jpn. 22:1981;1559-1568.
68. Kornfeld S., Reitman M.L., Kornfeld R. The carbohydrate-binding specificity of pea and lentil lectins. J. Biol. Chem. 256:1981;6633-6640.
69. Taketa K., Ichikawa E., Taga H., Hirai H. Antibody-affinity blotting, a sensitive technique for the detection of α-fetoprotein separated by lectin affinity electrophoresis in agarose gels. Electrophoresis. 6:1985;492-497.
70. Taketa K. A tetrazolium method for peroxidase staining; application to the antibody-affinity blotting of α-fetoprotein in cancer diagnosis. Electrophoresis. 8:1987;409-414.
71. Aoyagi Y., Isemura Y., Yoshizawa Z., Suzuki Y., Sekine C., Ono T., et al. Fucosylation of serum α-fetoprotein with primary hepatocellular carcinoma. Biochim. Biophys. Acta. 830:1985;217-223.
72. Suzuki Y., Aoyagi Y., Muramatsu M., Sekine C., Isemura M., Ichida F. Close topographical relationship in α fetoprotein (AFP) between a Lens culinaris binding glycan and the epitope recognized by AFP-reactive monoclonal antibody, 18H4. Br. J. Cancer. 55:1987;147-152.
73. Aoyagi Y., Suzuki Y., Igarashi K., Saitoh A., Oguro M., Yokota T., Mori S., et al. The usefulness of simultaneous determinations of glucosaminylation and fucosylation induces of α-fetoprotein in the differential diagnosis of neoplastic diseases of the liver. Cancer. 67:1991;2390-2394.
74. Taketa K., Sekiya C., Namiki M., Akamatsu K., Ohta Y., Endo Y., Kosaka K. Lectin-reactive profiles of α-fetoprotein characterizing hepatocellular carcinoma and related conditions. Gastroenterology. 99:1990;508-518.
75. Taketa K., Endo Y., Sekiya C., Tanikawa K., Taga H., Satomura S., Matsuura S., Kawai T., Hirai H. A collaborative study for the evaluation of lectin-reactive α-fetoprotein in early detection of hepatocellular carcinoma. Cancer Res. 53:1993;5419-5423.
76. Sato Y., Nakata K., Kato Y., Shima M., Ishii N., Koji T., Taketa K., Endo Y., Nagataki S. Early recognition of hepatocellular carcinoma based on altered profiles of α-fetoprotein. N. Engl. J. Med. 328:1993;1802-1806.
77. Shiraki K., Takase K., Tameda Y., Hamada M., Kosaka Y., Nakano T. A clinical study of lectin-reactive α-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients. Hepatology. 22:1995;802-807.
78. Yamashita F., Tanaka M., Satomura S., Tanikawa K. Prognostic significance of Lens culinaris agglutinin-reactive α-fetoprotein in small hepatocellular carcinomas. Gastroenterology. 111:1996;996-1001.
79. Aoyagi Y., Isokawa O., Suda T., Watanabe M., Suzuki Y., Asakura H. The fucosylation index of α-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma. Cancer. 83:1998;2076-2082.
80. Taketa K. α-fetoprotein: reevaluation in hepatology. Hepatology. 12:1990;1420-1432.
81. Miyoshi E., Fujii J., Hayashi N., Taniguchi N. LEC rats: An overview of recent findings. J. Trace Elements Exp. Med. 10:1997;135-145.
82. Noda K., Miyoshi E., Uozumi N., Gao C.-X., Suzuki K., Hayashi N., Hori M., Taniguchi N. High expression of α1-6 fucosyltransferase during rat hepatocarcinogenesis. Int. J. Cancer. 75:1998;444-450.
83. Hutchinson W.L., Du M.-Q., Johnson P.J., Williams R. Fucosyltransferases: Differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis. Hepatology. 13:1991;683-688.
84. Ohno M., Nishikawa A., Koketsu M., Taga H., Endo Y., Hada T., Higashino K., Taniguchi N. Enzymatic basis of sugar structures of α-fetoprotein in hepatoma and hepatoblastoma cell lines: Correlation with activities of α1-6 fucosyltransferase and N-acetylglucosaminyltransferases III and V. Int. J. Cancer. 51:1992;315-317.
85. Noda K., Miyoshi E., Uozumi N., Ikeda Y., Gao C.-X., Suzuki K., Yoshihara H., Yoshikawa K., Kawano K., Hayashi N., Hori M., Taniguchi N. Gene expression of α1-6 fucosyltransferase in human hepatoma tissues: A possible implication for increased fucosylation of α fetoprotein. Hepatology. 28:1998;944-952.
86. Miyoshi E., Noda K., Ko J.H., Ekuni A., Kitada T., Uozumi N., Ikeda Y., Matsuura N., Sasaki Y., Hayashi N., Hori M., Taniguchi N. Overexpression of α1-6 fucosyltransferase in hepatoma cells suppresses intrahepatic metastasis after splenic injection in athymic mice. Cancer Res. 59:1999;2237-2243.
87. Stubbs H.J., Lih J.J., Gustafson T.L., Rice K.G. Influence of core fucosylation on the flexibility of a biantennary N-linked oligosaccharide. Biochemistry. 35:1996;937-947.
88. Kojima N., Yachida Y., Yoshida Y., Tsuji S. Characterization of mouse ST8SiaII(STX) as a neural cell adhesion molecule-specific polysialic acid synthase. J. Biol. Chem. 271:1996;19457-19463.
89. Suzuki T., Seko A., Kitajima K., Inoue Y., Inoue S. Purification and enzymatic properties of peptide N-glycanase from C3H mouse-derived L-929 fibroblast cells. Possible widespread occurrence of post-translational remodification of proteins by N-deglycosylation. J. Biol. Chem. 269:1994;17611-17618.
90. Ihara Y., Yoshimura M., Miyoshi E., Nishikawa A., Sultan A.S., Toyosawa S., Ohnishi A., Suzuki M., Yamamura K., Ijuhin N., Taniguchi N. Ectopic expression of N-acetylglucosaminyltransferase III in transgenic hepatocytes disrupts apolipoprotein B secretion and induces aberrant cellular morphology with lipid storage. Proc. Natl. Acad. Sci. USA. 95:1998;2526-2530.
91. Dennis J.W., Laferte S., Waghorne C., Breitman M.L., Kerbel R.S. β1-6 Branching of Asn-linked oligosaccharides is directly associated with metastasis. Science. 236:1987;582-585.
92. Yoshimura M., Nishikawa A., Ihara Y., Taniguchi S., Taniguchi N. Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc. Natl. Acad. Sci. USA. 92:1995;8754-8758.
93. Demetriou M., Nabi I.-R., Coppolino M., Dedhar S., Dennis J.W. Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J. Cell Biol. 130:1995;383-392.
94. Goupille C., Hallouin F., Meflah K., Pendu J.-L. Increase of rat colon carcinoma cells tumorigenicity by α(1-2) fucosyltransferase gene transfection. Glycobiology. 7:1997;221-229.